CRSP logo

CRISPR Therapeutics AG (CRSP)

Profile

Full Name

CRISPR Therapeutics AG

Ticker Symbol

CRSP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

October 19, 2016

Indexes

Not included

Website

http://www.crisprtx.com

Employees

393

Key Details

Price

$47.22(+0.94%)

Market cap

$4.08B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$35.00M(-90.54% YoY)

Annual EPS

-$4.34(-123.71% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $47.22
    CRSP price is $47.22

    30-Day Relative Volume

    1.13
    CRSP 30-day relative volume is 1.13

    Price Performance

    Price Today change

    +0.94%
    CRSP price is up +0.94% today

    Price YTD change

    +19.97%
    CRSP price is up +19.97% since January 1st

    Price 1-year change

    -15.6%
    CRSP price is down -15.6% year-on-year

    Price 3-year change

    -29.48%
    CRSP price is down -29.48% over the past 3 years

    Price Range

    Price All-time high

    $220.20
    CRSP price is currently -78.56% below its historical high of $220.20

    Price 3-year low

    $30.04
    CRSP price is currently +57.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.08B
    CRSP market capitalization is $4.08 billion

    Market cap 3-year change

    -21.37%
    CRSP market capitalization is down -21.37% over the past 3 years

    Market cap All-time high

    $15.53B
    CRSP market capitalization is currently -73.73% below its historical high of $15.53 billion

    Market cap sector rank

    87.89%
    CRSP market capitalization is higher than 87.89% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.7%
    CRSP shares outstanding is up +1.7% year-on-year

    Shares Outstanding 3-Year Change

    +11.5%
    CRSP shares outstanding is up +11.5% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.29
    CRSP beta is 1.29

    200-day SMA

    $43.10
    CRSP price is currently +9.56% above its 200-day simple moving average

    50-day SMA

    $38.87
    CRSP price is currently +21.49% above its 50-day simple moving average

    RSI

    74.22
    CRSP 14-day relative strength index is 74.22

    Volume

    1.13
    CRSP 30-day relative volume is 1.13

    ATR

    $2.32
    CRSP average true range is $2.32

    10-day Historical Volatility

    34.82%
    CRSP 10-day historical volatility is 34.82%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $35.00M
    CRSP annual revenue is $35.00 million

    Revenue Analysts estimate

    $50.78M
    CRSP annual revenue is currently -31.07% lower than the consensus analysts' forecast

    Revenue 1-year change

    -90.54%
    CRSP annual revenue is down -90.54% year-on-year

    Revenue Sector rank

    41.97%
    CRSP annual revenue is higher than 41.97% of companies in Healthcare sector

    EPS

    EPS

    -$4.34
    CRSP annual earnings per share is -$4.34

    EPS Analysts estimate

    -$5.43
    CRSP annual earnings per share is currently -20.03% lower than the consensus analysts' forecast

    EPS 1-year change

    -123.71%
    CRSP annual earnings per share is down -123.71% year-on-year

    EPS Sector rank

    22.06%
    CRSP annual earnings per share is higher than 22.06% of companies in Healthcare sector

    Profit

    Gross profit

    -$75.25M
    CRSP annual gross profit is -$75.25 million

    Gross margin

    -215.00%
    CRSP annual gross profit margin is -215.00%

    Operating profit

    -$466.57M
    CRSP annual operating income is -$466.57 million

    Operating margin

    -1333.05%
    CRSP annual operating profit margin is -1333.05%

    Net income

    -$366.25M
    CRSP annual net profit is -$366.25 million

    Net margin

    -1046.43%
    CRSP annual net profit margin is -1046.43%

    Expenses

    Total expenses

    $501.57M
    CRSP annual total expenses is $501.57 million

    Operating expenses

    $391.32M
    CRSP annual total operating expenses is $391.32 million

    Cost of goods sold

    $110.25M
    CRSP annual cost of goods sold is $110.25 million

    Selling, general & administrative expenses

    $72.98M
    CRSP annual SGA is $72.98 million

    Depreciation and amortization

    $19.26M
    CRSP annual depreciation & amortization is $19.26 million

    Interest expense

    -
    CRSP annual interest expense value is unknown

    Income tax

    $3.59M
    CRSP annual income tax is $3.59 million

    EBIT & EBITDA

    EBIT

    -$466.57M
    CRSP annual earnings before interest & taxes is -$466.57 million

    EBITDA

    -$447.31M
    CRSP annual EBITDA is -$447.31 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.24B
    CRSP annual total assets is $2.24 billion

    Non current assets

    $304.90M
    CRSP annual long term assets is $304.90 million

    Current assets

    $1.94B
    CRSP annual total current assets is $1.94 billion

    Cash and cash equivalents

    $298.26M
    CRSP annual cash & cash equivalents is $298.26 million

    Accounts receivable

    $25.00M
    CRSP annual accounts receivable is $25.00 million

    Inventory

    -
    CRSP annual inventory value is unknown

    Liabilities

    Total liabilities

    $309.95M
    CRSP annual total liabilities is $309.95 million

    Long term liabilities

    $222.17M
    CRSP annual total long term liabilities is $222.17 million

    Current liabilities

    $87.78M
    CRSP annual total current liabilities is $87.78 million

    Accounts payable

    $14.71M
    CRSP annual accounts payable is $14.71 million

    Debt

    Total debt

    $223.69M
    CRSP annual total debt is $223.69 million

    Total debt 1-year change

    -6.26%
    CRSP annual total debt is down -6.26% year-on-year

    Long term debt

    $206.41M
    CRSP annual long term debt is $206.41 million

    Short term debt

    $17.29M
    CRSP annual short term debt is $17.29 million

    Equity & Capital

    Shareholders equity

    $1.93B
    CRSP annual stockholders equity is $1.93 billion

    Book value

    $1.93B
    CRSP annual book value is $1.93 billion

    Retained earnings

    -$1.37B
    CRSP annual retained earnings is -$1.37 billion

    Working capital

    $1.85B
    CRSP annual working capital is $1.85 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$142.77M
    CRSP annual cash flow from operations is -$142.77 million

    Cash from operations 1-year change

    +45.17%
    CRSP annual cash flow from operations is up +45.17% year-on-year

    Cash from investing

    -$280.48M
    CRSP annual cash flow from investing activities is -$280.48 million

    Cash from investing 1-year change

    -174.87%
    CRSP annual cash flow from investing activities is down -174.87% year-on-year

    Cash from financing

    $331.98M
    CRSP annual cash flow from financing activities is $331.98 million

    Cash from financing 1-year change

    +429.78%
    CRSP annual cash flow from financing activities is up +429.78% year-on-year

    CAPEX

    CAPEX

    $1.90M
    CRSP annual capital expenditures is $1.90 million

    CAPEX 1-year change

    -84.12%
    CRSP annual capital expenditures is down -84.12% year-on-year

    Free Cash Flow

    Free cash flow

    -$144.68M
    CRSP annual free cash flow is -$144.68 million

    Free cash flow 1-year change

    +46.88%
    CRSP annual free cash flow is up +46.88% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -215.00%
    CRSP annual gross profit margin is -215.00%

    Operating margin

    -1333.05%
    CRSP annual operating profit margin is -1333.05%

    Net margin

    -1046.43%
    CRSP annual net profit margin is -1046.43%

    ROA & ROE

    ROA

    -16.38%
    CRSP annual return on assets is -16.38%

    ROE

    -19.20%
    CRSP annual return on equity is -19.20%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CRSP price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CRSP price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.23
    CRSP price to book ratio is 2.23

    PB ratio Sector rank

    60.93%
    CRSP price to book ratio is higher than 60.93% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CRSP price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CRSP price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $4.06B
    CRSP enterprise value is $4.06 billion

    Enterprise value Sector rank

    86.55%
    CRSP enterprise value is higher than 86.55% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -8.92
    CRSP EV/EBITDA is -8.92

    EV/EBITDA Sector rank

    14.63%
    CRSP EV/EBITDA is higher than 14.63% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    22.07
    CRSP annual current ratio is 22.07

    Quick ratio

    -
    CRSP annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CRSP annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CRSP annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CRSP piotroski f-score value is unknown

    Altman Z-Score

    7.36
    CRSP altman z-score is 7.36

    Analyst ratings

    Recent major analysts updates

    May 21, 25 JMP Securities
    Market Outperform
    May 20, 25 Needham
    Buy
    May 20, 25 HC Wainwright & Co.
    Buy
    May 9, 25 Barclays
    Equal-Weight
    May 8, 25 Goldman Sachs
    Neutral
    May 7, 25 Needham
    Buy
    May 7, 25 Chardan Capital
    Buy
    Apr 9, 25 Needham
    Buy
    Feb 19, 25 Cantor Fitzgerald
    Neutral
    Feb 18, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with CRSP included

    Growing Shares Outstanding
    Mid cap stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for CRISPR Therapeutics AG?
    • Does CRISPR Therapeutics AG pay dividends?
    • What sector is CRISPR Therapeutics AG in?
    • What industry is CRISPR Therapeutics AG in?
    • What country is CRISPR Therapeutics AG based in?
    • When did CRISPR Therapeutics AG go public?
    • Is CRISPR Therapeutics AG in the S&P 500?
    • Is CRISPR Therapeutics AG in the NASDAQ 100?
    • Is CRISPR Therapeutics AG in the Dow Jones?
    • When was CRISPR Therapeutics AG's last earnings report?
    • When does CRISPR Therapeutics AG report earnings?
    • Should I buy CRISPR Therapeutics AG stock now?

    What is the ticker symbol for CRISPR Therapeutics AG?

    The ticker symbol for CRISPR Therapeutics AG is NASDAQ:CRSP

    Does CRISPR Therapeutics AG pay dividends?

    No, CRISPR Therapeutics AG does not pay dividends

    What sector is CRISPR Therapeutics AG in?

    CRISPR Therapeutics AG is in the Healthcare sector

    What industry is CRISPR Therapeutics AG in?

    CRISPR Therapeutics AG is in the Biotechnology industry

    What country is CRISPR Therapeutics AG based in?

    CRISPR Therapeutics AG is headquartered in Switzerland

    When did CRISPR Therapeutics AG go public?

    CRISPR Therapeutics AG's initial public offering (IPO) was on October 19, 2016

    Is CRISPR Therapeutics AG in the S&P 500?

    No, CRISPR Therapeutics AG is not included in the S&P 500 index

    Is CRISPR Therapeutics AG in the NASDAQ 100?

    No, CRISPR Therapeutics AG is not included in the NASDAQ 100 index

    Is CRISPR Therapeutics AG in the Dow Jones?

    No, CRISPR Therapeutics AG is not included in the Dow Jones index

    When was CRISPR Therapeutics AG's last earnings report?

    CRISPR Therapeutics AG's most recent earnings report was on May 6, 2025

    When does CRISPR Therapeutics AG report earnings?

    The next expected earnings date for CRISPR Therapeutics AG is Aug 5, 2025

    Should I buy CRISPR Therapeutics AG stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page